Volume 7, Issue 2 (6-2025)
sjmshm 2025, 7(2): 1-12 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azizi T, Fouladi A. The effectiveness of group schema therapy on health anxiety and treatment adherence in coronary heart disease patients. sjmshm 2025; 7 (2) :1-12
URL: http://sjmshm.srpub.org/article-3-242-en.html
URL: http://sjmshm.srpub.org/article-3-242-en.html
Assistant Professor, Department of Psychology, Tabaran Institute of Higher Education, Mashhad, Iran
Abstract: (54 Views)
This study aimed to determine the effectiveness of group schema therapy on health anxiety and treatment adherence in coronary heart disease patients. This study was a quasi-experimental design with pre-test, post-test, and two experimental and control groups. The statistical population included all patients with coronary heart disease referred to hospitals in Mashhad. The research sample was 30 people using the available sampling method, including attrition, who were randomly assigned to the experimental and control groups (15 people in each group). In order to measure the research variables, the health anxiety questionnaires of Warwick & Salkovski (2002) and treatment adherence questionnaires of Morisky et al. (2008) were administered to the sample group members. The experimental group members underwent Young's (2003) group schema therapy for 8 sessions of 90 minutes, and the control group did not receive any training. The data were analyzed using the multivariate analysis of covariance test using SPSS-27 software. The findings showed that the pre-test probability value for the variables of health anxiety and treatment adherence compared to the post-test values of those variables was less than 0.05, indicating their significant effect at the five percent error level (P<0.005). The results showed that group schema therapy is effective for health anxiety and treatment adherence in coronary heart disease patients, so it is suggested that the group schema therapy program be considered as an effective treatment in coronary heart disease patients.
Keywords: Group schema therapy, health anxiety, treatment adherence, coronary heart disease patients.
Type of Study: Research |
Subject:
Psychiatry and Mental Health
Received: 2025/02/2 | Revised: 2025/04/21 | Accepted: 2025/06/10 | Published: 2025/06/10
Received: 2025/02/2 | Revised: 2025/04/21 | Accepted: 2025/06/10 | Published: 2025/06/10
References
1. World Health Organization. Cardiovascular diseases (CVDs) [Internet]. 2023 [cited 2026 Apr 10]. Available from:
2. Siahkuhian M, Fasehi L, Ebrahimi Turkmani B. Predicting coronary artery disease using discriminant analysis algorithm in active elderly men. Journal of Ardabil University of Medical Sciences. 2022;22(4):370-9. Persian. [DOI:10.52547/jarums.22.4.370]
3. Tang MM, Zhao ST, Li RQ, Hou W. Therapeutic mechanisms of ginseng in coronary heart disease. Front Pharmacol. 2023;14:1271029. [DOI:10.3389/fphar.2023.1271029] [PMID]
4. Khusainova MA. Comorbidity thyrotoxicosis with coronary heart disease. Science and Education. 2023;4(5):205-13.
5. Barzegari A, Norani SF, Mirzaei M. Comparison of data mining algorithms performance in predicting coronary artery diseases using Yazd Health Study (YaHS) data. Journal of Shahid Sadoughi University of Medical Sciences. 2023;31(7):6824-35. [DOI:10.18502/ssu.v31i7.13693]
6. Inwood E, Ferrari M. Mechanisms of change in the relationship between self-compassion, emotion regulation, and mental health: A systematic review. Appl Psychol Health Well-Being. 2018;10(2):215-35. [DOI:10.1111/aphw.12127] [PMID]
7. Van der Wal M, Jaarsma T, Van Veldhuisen DJ. Non-compliance in patients with heart failure: how can we manage it? Eur J Heart Fail. 2005;7(1):5-17. [DOI:10.1016/j.ejheart.2004.04.007] [PMID]
8. Shay LE. A concept analysis: adherence and weight loss. Nurs Forum. 2008;43(1):42-52. [DOI:10.1111/j.1744-6198.2008.00095.x] [PMID]
9. Dilas D, Flores R, Morales-García WC, Calizaya-Milla YE, Morales-García M, Sairitupa-Sanchez L, et al. Social support, quality of care, and patient adherence to tuberculosis treatment in Peru: the mediating role of nurse health education. Patient Prefer Adherence. 2023;17:175-86. [DOI:10.2147/PPA.S391930] [PMID]
10. Darahani D, Lekka D, Anagnosti F, Anthouli-Anagnostopoulou F, Papagiorgis P, Chaniotis D, et al. The effect of psychiatric disorders and stressful environmental factors in correlation with smoking and coronary heart disease. Psychology. 2023;14(9):1519-33. [DOI:10.4236/psych.2023.149088]
11. Chen X, Zeng M, Chen C, Zhu D, Chen L, Jiang Z. Efficacy of Psycho-Cardiology therapy in patients with acute myocardial infarction complicated with mild anxiety and depression. Front Cardiovasc Med. 2022;9:1031255. [DOI:10.3389/fcvm.2022.1031255] [PMID]
12. Tariq A, Quayle E, Lawrie SM, Reid C, Chan SW. Relationship between early maladaptive schemas and anxiety in adolescence and young adulthood: A systematic review and meta-analysis. J Affect Disord. 2021;295:1462-73. [DOI:10.1016/j.jad.2021.09.031] [PMID]
13. Young JE, Klosko JS, Weishaar ME. Schema therapy: A practitioner's guide. New York: Guilford Press; 2003. (Translated by Hamidpour H, Andouz Z. 2021. Tehran: Arjmand Pub.).
14. Yousefi N, Asghari M, Toghyani M. The relationship between early maladaptive schemas and emotional regulation with marital satisfaction. Journal of Family Research. 2016;12(2):197-214.
15. Vitasari P, Nubli Abdul MW, Herawan T, Othman A, Kumar Sinnadurai S. Re-test of State Trait Anxiety Inventory (STAI) among Engineering Students in Malaysia: Reliability and Validity tests. Procedia Soc Behav Sci. 2011;15:3843-8. [DOI:10.1016/j.sbspro.2011.04.383]
16. Asmundson GJG, Taylor S. It's not all in your head: how worrying about your health could be making you sick - and what you can do about it. New York: Guilford Press; 2005.
17. Tyrer P, Tyrer H. Health anxiety: detection and treatment. BJPsych Adv. 2018;24(1):66-72. [DOI:10.1192/bja.2017.5]
18. McDaniel SH, Grus CL, Cubic BA, Hunter CL, Kearney LK, Schuman CC, et al. Competencies for psychology practice in primary care. Am Psychol. 2014;69(4):409-29. [DOI:10.1037/a0036072]
19. Longley SL, Broman-Fulks JJ, Calamari JE, Noyes R, Wade M, Orlando CM. A taxometric study of hypochondriasis symptoms. Behav Ther. 2010;41(4):505-14. [DOI:10.1016/j.beth.2010.02.002] [PMID]
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013. [DOI:10.1176/appi.books.9780890425596]
21. Thomas AF, Kelley LP, Griggs JO. The combination of health anxiety and somatic symptoms: Specificity to anxiety sensitivity cognitive concerns among patients in primary care. Psychiatry Res. 2016;239:117-21. [DOI:10.1016/j.psychres.2016.02.067] [PMID]
22. Young JE, Klosko JS, Weishaar ME. Schema therapy: A practitioner's guide. New York: Guilford Press; 2013.
23. Ahmadi F, Goodarzi K, Farrokhi N, Roozbahani M. Comparison of the effectiveness of acceptance and commitment therapy and schema therapy on resilience among patients with cardiovascular disease: A pilot study. Cardiovascular Health. 2021;8(4):1-10.
24. Cepeda-Valery B, Cheong AP, Lee A, Yan BP. Measuring health related quality of life in coronary heart disease: the importance of feeling well. Int J Cardiol. 2012;149(1):4-9. [DOI:10.1016/j.ijcard.2010.09.048] [PMID]
25. Fiers AG, Teral TJ. Clinical psychology. 5th ed. Tehran: Roshd Publication; 2021. p. 343-68. [Persian].
26. Rychter A, Miniszewska J, Góra-Tybor J. Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality. BioPsychoSocial Med. 2023;17(1):1. [DOI:10.1186/s13030-023-00261-w] [PMID]
27. Hokmabadi ME, Bigdeli I, Asadi J, Asghari Ebrahimabad MJ. The effectiveness of schema therapy on type D personality on working memory, prospective memory and treatment adherence in coronary heart patients. Journal of Disability Studies. 2019;9(1):1-10.
28. Hokmabadi ME, Bigdeli I, Asadi J, Asghari Ebrahimabad MJ. Comparison of the effectiveness of schema therapy with acceptance and commitment therapy on type D personality syndrome and treatment adherence in coronary heart patients. Journal of Clinical Psychology. 2020;12(1):25-36.
29. Ghasempour H, Darzi Azadboni M, Mirzaeian B, Sangani A, Shakarian S. Modeling early maladaptive schemas on treatment adherence with the mediating role of cognitive emotion regulation and resilience in coronary heart patients. Iranian Journal of Nursing Education. 2022;11(4):13-24.
30. Rayner AL. Therapist adherence in cognitive behavioural therapy and schema therapy for depression [dissertation]. University of Canterbury; 2019.
31. Warwick, H. M. C., & Salkovskis, P. M. Hypochondriasis. In G. C. L. Davey & F. Tallis (Eds.) , Worrying: Perspectives on theory, assessment and treatment. (pp. 241-259). Wiley.2002.
32. Asmundson, G. J. G., Abramowitz, J. S., Richter, A. A., & Whedon, M. Health anxiety: Current perspectives and future directions. Current Psychiatry Reports, 2010;12(4), 306-312. [DOI:10.1007/s11920-010-0123-9] [PMID]
33. Bagheri Sheikhangafshe F, Shabahang T, Moghaddam H, Sharifipour Chookami Z, Mousavi SM. The role of health anxiety, anxiety sensitivity, and somatosensory amplification in predicting COVID-19 anxiety in students. Psychological Studies. 2020;16(4):77-91.
34. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54. [DOI:10.1111/j.1751-7176.2008.07572.x] [PMID]
35. Mehrtak M, Hemmati A, Bakhshzadeh A. Health literacy and its relationship with the medical, dietary adherence and exercise in patients with type II diabetes mellitus. Journal of Health Literacy. 2018;3(2):137-44.
36. Mohaghegh A, Tajeri B, Keramati H. Comparison of the effectiveness of schema therapy and emotion-focused therapy on treatment adherence in patients with multiple sclerosis. Journal of Psychological Science. 2025;24(145):81-95.
37. Zarei S, Fooladwand K. The effectiveness of schema therapy on negative affect and perceived stress in coronary artery disease patients. Knowledge & Research in Applied Psychology. 2023;1(24):151-62.
38. Khosrowshahi H, Mirzaeian B, Hassanzadeh R. The effectiveness of acceptance and commitment therapy on illness perception in coronary heart patients. Journal of Disability Studies. 2019;9(1):1-10.
39. Azizi Z, Aliakbari Dehkordi M, Alipour A. The effectiveness of group schema therapy on reducing death anxiety syndrome in cardiovascular patients. Journal of Research in Behavioural Sciences. 2019;17(2):244-52. [DOI:10.52547/rbs.17.2.244]
40. Baljé AE, Greeven A, Deen M, van Giezen AE, Arntz A, Spinhoven P. Group schema therapy versus group cognitive behavioral therapy for social anxiety disorder with comorbid avoidant personality disorder: A randomized controlled trial. J Anxiety Disorder. 2024;102:102860. [DOI:10.1016/j.janxdis.2024.102860] [PMID]
41. Kort Y, Arntz A, van der Gaag M. Short-term, manualized schema-focused group therapy: feasibility and preliminary effectiveness. Front Psychol. 2024;15:1349329.
42. Lodder P, Wicherts JM, Antens M, Albus C, Bessonov IS, Condén E, et al. Type D personality as a risk factor for adverse outcome in patients with cardiovascular disease: An individual patient data meta-analysis. Psychosom Med. 2023;85(5):409-17. [DOI:10.1097/PSY.0000000000001164] [PMID]
43. Halford J, Brown C, Thompson AR, Jones A. Schema therapy for anxiety disorders: A systematic review of its effectiveness. Clin Psychol Psychother. 2023;30(1):24-38.
44. Yu M, Wang L, Guan L, Qian M, Lv J, Deng M. Knowledge, attitudes, and barriers related to medication adherence of older patients with coronary heart disease in China. Geriatr Nurs. 2022;43:235-41. [DOI:10.1016/j.gerinurse.2021.12.001] [PMID]
45. Kauw D, Schoormans D, Sieswerda GT, Van Melle JP, Vliegen HW, Van Dijk APJ, et al. Type D personality associated with increased risk for mortality in adults with congenital heart disease. J Cardiovasc Nurs. 2022;37(2):192-6. [DOI:10.1097/JCN.0000000000000747] [PMID]
46. Bamelis LLM, Evers SMAA, Spinhoven P, Arntz A. Effectiveness of predominantly group schema therapy and combined individual-group schema therapy for borderline personality disorder: A randomized clinical trial. JAMA Psychiatry. 2022;79(4):287-99. [DOI:10.1001/jamapsychiatry.2022.0010] [PMID]
47. Chang Y, Zhang L, Duan Y, Liu X. Effects of online mindfulness interventions on patients with cardiovascular disease: A randomized controlled trial. J Psychosom Res. 2021;145:110484.
48. Berg SK, Herning M, Schjødt I, Thorup CB, Juul C, Svendsen JH, et al. The heart & mind trial: intervention with cognitive-behavioural therapy in patients with cardiac disease and anxiety: randomised controlled trial protocol. BMJ Open. 2021;11(12):e057085. [DOI:10.1136/bmjopen-2021-057085] [PMID]
49. Zhang L, Liu X, Li Q, Wang H, Duan Y. Effectiveness of mindfulness-based interventions on cardiovascular patients: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract. 2021;43:101358.
50. Silarova B, Nagyova I, Rosenberger J, van Dijk JP, Reijneveld SA. Sense of coherence as a mediator between hostility and health-related quality of life among coronary heart disease patients. Heart Lung. 2016;45(2):126-31. [DOI:10.1016/j.hrtlng.2015.11.004] [PMID]
51. Denollet J. Personality, emotional distress and coronary heart disease. In: van den Bosch K, Maes R, editors. Psychological perspectives on chronic illness. Springer; 2015. p. 131-54.
52. Young JE, Klosko JS, Weishaar ME. Schema therapy: A practitioner's guide. New York: Guilford Press; 2013.
53. Young JE, Klosko JS, Weishaar ME. Schema therapy: A practitioner's guide. New York: Guilford Press; 2003. (Translated by Hamidpour H, Andouz Z. 2021. Tehran: Arjmand Pub.).
54. Wisuda AC, bin Sansuwito T, Suraya C. Enhancing quality of life: Murottal spiritual care for reducing anxiety and depression in coronary heart disease patients-a holistic systematic review. Int J Sci Prof. 2024;3(1):240-6. [DOI:10.56988/chiprof.v3i1.62]
55. Morys JM, Bellwon J, Hofer S, Rynkiewicz A, Gruchała M. Quality of life in patients with coronary heart disease after myocardial infarction and with ischemic heart failure. Arch Med Sci. 2016;12(2):326-33. [DOI:10.5114/aoms.2014.47881] [PMID]
56. Kähkönen O, Saaranen T, Kankkunen P, Lamidi ML, Kyngäs H, Miettinen H. Predictors of adherence to treatment by patients with coronary heart disease after percutaneous coronary intervention. J Clin Nurs. 2018;27(5-6):989-1003. [DOI:10.1111/jocn.14153] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |